AbCheck sro:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:AbCheck sro - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10637
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:チェコ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
AbCheck Sro (AbCheck), a subsidiary of Affimed NV is a healthcare technology company offers discovery and optimization of high-quality human antibodies. The company offers technology platforms such as Absieve, and AbAccel. Its Absieve is an antibody discovery technology that offers proprietary phage display libraries and yeast display. AbCheck’s AbAccel is a proprietary algorithm for affinity maturation and lead optimization that enables the computational identification of specificity determining residues for a given candidate. The company partners with various medical companies and institutions. AbCheck is headquartered in Plzen, the Czech Republic.

AbCheck sro – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
AbCheck sro, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AbCheck sro, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
AbCheck sro, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AbCheck sro, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
AbCheck sro, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
AbCheck sro, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
MolMed and AbCheck Enter into Agreement 10
AbCheck and Molecular Templates Enter into Agreement 11
AbCheck Expands Research Agreement with Pierre Fabre Pharma 12
AbCheck Enters Into Research Agreement With Pierre Fabre 13
Abcheck Enters Into Research Agreement With U3 Pharma 14
Licensing Agreements 15
AbCheck Enters Into Licensing Agreement With Distributed Bio For mAB Technology 15
AbCheck sro – Key Competitors 16
AbCheck sro – Key Employees 17
AbCheck sro – Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Strategy And Business Planning 19
Oct 30, 2018: AbCheck, a leader in providing antibody drug discovery and optimization services, announces its United States presence with AbCheck 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
AbCheck sro, Pharmaceuticals & Healthcare, Key Facts 2
AbCheck sro, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AbCheck sro, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
AbCheck sro, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AbCheck sro, Deals By Therapy Area, 2012 to YTD 2018 8
AbCheck sro, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
MolMed and AbCheck Enter into Agreement 10
AbCheck and Molecular Templates Enter into Agreement 11
AbCheck Expands Research Agreement with Pierre Fabre Pharma 12
AbCheck Enters Into Research Agreement With Pierre Fabre 13
Abcheck Enters Into Research Agreement With U3 Pharma 14
AbCheck Enters Into Licensing Agreement With Distributed Bio For mAB Technology 15
AbCheck sro, Key Competitors 16
AbCheck sro, Key Employees 17

List of Figures
AbCheck sro, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
AbCheck sro, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
AbCheck sro, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
AbCheck sro, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
AbCheck sro, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AbCheck sro, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
AbCheck sro, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AbCheck sro, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[AbCheck sro:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Atlas Iron Ltd:企業のM&A・事業提携・投資動向
    Atlas Iron Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Atlas Iron Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development:製薬・医療:M&Aディール及び事業提携情報
    Summary Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), a subsidiary of National Institutes of Health, is a research institute that conducts and supports laboratory research, clinical trials, and epidemiological studies. The institute conducts research in the …
  • Vericel Corp (VCEL)-製薬・医療分野:企業M&A・提携分析
    Summary Vericel Corp (Vericel) formerly Aastrom Biosciences, Inc. is a medical device company that develops patient-specific expanded cellular therapies to repair and regenerate damaged tissue for the treatment of severe, chronic ischemic cardiovascular diseases. It markets two autologous cell thera …
  • Bureau Veritas SA (BVI)-エネルギー分野:企業M&A・提携分析
    Summary Bureau Veritas SA (Bureau Veritas) is a testing, inspection and certification service provider that offers varied services such as asset management, certification, classification, consulting, inspection and audits, testing and analysis, and training. The company serves aeronautics, agricultu …
  • Cerner Corp (CERN):企業の財務・戦略的SWOT分析
    Cerner Corp (CERN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Edwards Lifesciences Corp (EW):企業の財務・戦略的SWOT分析
    Edwards Lifesciences Corp (EW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Legrand SA:企業の戦略・SWOT・財務情報
    Legrand SA - Strategy, SWOT and Corporate Finance Report Summary Legrand SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Coty Inc.:企業の戦略・SWOT・財務情報
    Coty Inc. - Strategy, SWOT and Corporate Finance Report Summary Coty Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Poxel SA (POXEL):企業の財務・戦略的SWOT分析
    Summary Poxel SA (Poxel) is a biopharmaceutical company that focuses to develop drugs for metabolic diseases. The company’s pipeline product portfolio includes Imeglimin, which is developed to target mitochondrial dysfunction, for the treatment of type 2 diabetes; PXL065, a mitochondrial pyruvate ca …
  • Medpace Holdings Inc (MEDP):製薬・医療:M&Aディール及び事業提携情報
    Summary Medpace Holdings Inc (Medpace) is a scientifically-driven full-service clinical contract research organization. It provides Phase I-IV outsourced clinical development services. The company also offers clinical pharmacology; and supporting laboratory services including central laboratory, bio …
  • Lonestar Heart Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Lonestar Heart Inc (Lonestar Heart) is a pharmaceutical company that focuses on the development of novel cardiac restorative therapies for advanced heart failure. The company offers Algisyl cardiac implantable hydrogel and MyoTec system. Its Algisyl product provides a new treatment option fo …
  • DaVita Inc.:戦略・SWOT・企業財務分析
    DaVita Inc. - Strategy, SWOT and Corporate Finance Report Summary DaVita Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Codan Radio Communications:企業の戦略・SWOT・財務情報
    Codan Radio Communications - Strategy, SWOT and Corporate Finance Report Summary Codan Radio Communications - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Aerospace Industrial Development Corporation:企業の戦略・SWOT・財務情報
    Aerospace Industrial Development Corporation - Strategy, SWOT and Corporate Finance Report Summary Aerospace Industrial Development Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operati …
  • Cantel Medical Corp (CMD):企業の財務・戦略的SWOT分析
    Cantel Medical Corp (CMD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Osiris Therapeutics Inc (OSIR):企業の財務・戦略的SWOT分析
    Osiris Therapeutics Inc (OSIR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • RedHill Biopharma Ltd (RDHL):製薬・医療:M&Aディール及び事業提携情報
    Summary RedHill Biopharma Ltd (RedHill) is a biopharmaceutical company that develops and commercializes therapeutics in the areas of gastroenterology (GI) and cancer. The company’s commercial product portfolio consists of Donnatal for IBS and acute enterocolitis; Esomeprazole Strontium Delayed-Relea …
  • Fcmb Group Plc
    Fcmb Group Plc - Strategy, SWOT and Corporate Finance Report Summary Fcmb Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • National Mobile Telecommunications Company K.S.C.P.:企業の戦略・SWOT・財務情報
    National Mobile Telecommunications Company K.S.C.P. - Strategy, SWOT and Corporate Finance Report Summary National Mobile Telecommunications Company K.S.C.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's stru …
  • AbbVie Inc (ABBV):企業の財務・戦略的SWOT分析
    AbbVie Inc (ABBV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆